CEP164 p.Val1457=
c.4371G>A · rs781453124 · VCV1598539
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation/SpliceAI carries the signal. | ||
| Splicing | ||
| SpliceAI | Δ0.24 | donor gain · deltas |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.1 | GERP -3.1, phastCons 1 |
| Overall | ||
| CADD | 7.091 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.024% | 4,163 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,480 |
| European (non-Finnish) | 8.47e-05% | 1,179,993 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEP164
- Protein
- p.Val1457=
- Coding
- c.4371G>A
- MANE Select
- NM_014956
- dbSNP
- rs781453124
- Type
- single nucleotide variant
- Location
- chr11:117412156 (GRCh38)
- Gene constraint
- LOEUF 1.009 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.08 · 4 PDB
Disease context
nephronophthisis 15 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Senior-Loken syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- CEP164 c.1234-2A>T Likely pathogenic ★★ same condition
- CEP164 c.1724+1G>A Likely pathogenic ★★ same condition
- CEP164 c.1934+1G>A Likely pathogenic ★★ same condition
- CEP164 c.2361+1G>A Likely pathogenic ★★ same condition
- CEP164 c.2493+1G>A Likely pathogenic ★★ same condition
- CEP164 c.2914-1G>C Likely pathogenic ★★ same condition
- CEP164 c.3748+2T>C Likely pathogenic ★★ same condition
- CEP164 c.3749-2A>G Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep164-p-val1457 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown